Baxter International Inc (NYSE:BAX) is a component of the 162 company Health Care Equipment & Supplies GICS industry group, which is part of the 782 company GICS Health Care sector. The market value of BAX is $34.9 billion which places it in the top decile in its industry group. The stock's current Portfolio Grader score places it 7 among the 162 companies in this industry group, putting it in the top decile; among the sector leaders with a ranking of 14 among the 782 companies in the sector, and number 123 in the nearly 5,000 company Portfolio Grader universe.
Portfolio Grader currently ranks BAX as a Strong Buy. The methodology for investing incorporated in this tool, developed by Louis Navellier, researches and ranks approximately 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking BAX has had from Portfolio Grader for the last month.
Currently, Portfolio Grader ranks the Health Care sector number 9 among the 12 sectors in its universe putting it in the bottom quartile of all the GICS sectors. The Health Care Equipment & Supplies industry group is ranked 38 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.
Within the Portfolio Grader stock ranking system Baxter International has realized above-average scores in 6 of the 8 fundamental areas analyzed.
The company's operational scores provide mixed results with rankings for operating margin and earnings growth that are well above average, while the score for sales growth is below average. Scores for visibility of earnings are superior with a ranking for earnings revisions, earnings surprises and earnings momentum that are discernibly better than average. BAX's score for return on equity is better than its industry group average but its ranking for cash flow is below-average. Baxter International's fundamental scores give BAX a place in the top quartile of the industry group.
Portfolio Grader uses the Navellier Proprietary Quantitative Score to view BAX's shares from the aspect of risk/reward. This exclusive scoring system evaluates the relative value of the company's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Based on this risk/reward calculation, BAX currently scores well above-average in its industry group compared to its peers.
Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.
Commentary provided by UpTick Data Technologies.
